Meiosis is a process in which two consecutive cell divisions (MI and MII) occur in the absence of an intervening S-phase. MI is a reductional division in which homologous chromosomes are segregated, sister chromatids are only resolved following the equational MII division (Fig 1a). On completion of MI, oocytes prevent parthenogenetic activation by arresting their cell cycle at metaphase of MII (MetII) due to an activity termed Cytostatic Factor (CSF) 12. CSF blocks MetII exit until sperm break arrest via a cytoplasmic Ca²⁺ signal 345 which induces completion of MII.

Maturation (or M-Phase) Promoting Factor (MPF; CDK1/cyclin B) 67 activity drives somatic cells into mitosis and eggs into meiosis (for reviews see 8910). MPF is regulated during meiosis, oscillating in time with entry to, and exit from MI and MII (Fig 1b). The activity of MPF can be regulated by both CDK1 phosphorylation and cyclin B degradation (for reviews see 211). Hereafter cyclin B is used to denote any B-type cyclin degraded at metaphase, in frog this constitutes B1, B2, B4 and B5, while in mammals B1 and B2 1213. Most is known about cyclin B1 and B2 in frog and cyclin B1 in mammals. Mammalian cyclin B1 appears to be particularly important for eggs in Met II arrest, whereas B2 is non-essential and in all of this review, the use of cyclin B in the context of mammalian eggs actually refers to work carried out using cyclin B1 81415. At M-phase exit, as would occur at fertilization, loss of MPF is normally associated with the rapid destruction of cyclin B by anaphase 16 since CDK1 has no catalytic function without its regulatory partner 17. Cyclin B is degraded by a Destruction-box motif (D-box) in its primary sequence, which is recognized by the E3 ligase Anaphase Promoting Complex/Cyclosome (APC/C). The APC/C polyubiquitinates key cell cycle proteins such as cyclin B, targeting them for immediate proteolysis by the 26S proteasome 181920.

Eggs arrest at MetII with high MPF due to CSF activity (Fig 1c). The long-term stability of MPF is unique to eggs since in a mitotic metaphase, the APC/C would be active and cyclin B degraded. Although it is possible to exit CSF mediated MetII arrest by inhibiting the CDK1 component of MPF 2122, physiologically a sperm Ca²⁺ signal induces loss of cyclin B rather than CDK1 inactivation. Interestingly in mouse eggs, the APC/C is not completely inhibited during MetII arrest, such that eggs rely on continual cyclin B synthesis to maintain arrest 32324. Similarly in frog eggs, the APC/C remains active enough to degrade cyclin B 25. At fertilization, Ca²⁺ stimulates APC/C activity, in mouse about 6-fold 23, such that cyclin B degradation results in MPF loss. Blocking cyclin B degradation by D-box mutation prevents exit from MetII despite a Ca²⁺ signal 2627.

Unlike MPF, the identity of CSF has never been fully resolved, despite simultaneous identification of both activities in a seminal paper 28. Observations regarding the relationship between MPF and APC/C activity have led to the conclusion that CSF activity is likely to constitute an APC/C inhibitor 2. In mitosis, most is known about how the APC/C is inhibited by the spindle assembly checkpoint (SAC) proteins therefore we first discuss evidence that CSF activity is due to activation of the SAC pathway.

SAC proteins were identified in budding yeast mutants that lost ability to metaphase arrest after addition of spindle poisons 2930. SAC proteins function in arresting cells in metaphase by inhibiting the APC/C until all chromosomes are biorientated and so under tension from spindle microtubules (reviews see 313233). Vertebrate homologues of the SAC proteins Bub1 (Budding uninhibited by benzimidazole 1) Mad1 and Mad2 (Metaphase arrest deficient 1 and 2) have been suggested to affect MetII arrest in Xenopus eggs. Immunodepletion of these SAC proteins from egg extracts have all been demonstrated to block CSF arrest 3435.

SAC components have been implicated as the downstream effectors the c-Mos/MEK/MAPK/p90rsk pathway, long thought to be essential for frog CSF arrest. c-Mos (pp39mos), a proto-oncogene from a family of kinases functioning in signal transduction regulating cell growth and differentiation 36, is highly expressed during germ cell maturation, and has proposed roles throughout frog oocyte maturation 37383940414243. Functioning as a MAPK kinase kinase (MEKK), c-Mos is important for activation of the MAPK kinase, MEK1 444546. MEK1 serves as the upstream activator of MAPK 474849, which switches on the 90-kD ribosomal protein S6 kinase (p90rsk 50). At fertilization c-Mos is degraded 43, whilst MEK1, MAPK and p90rsk are inactivated shortly afterwards 5152.

The c-Mos ...p90rsk signaling cascade has been shown to aid directly MPF activation and stabilization 535455 making it an ideal CSF candidate. Microinjection of c-Mos RNA into two-cell embryos results in metaphase arrest, and immunodepletion of c-Mos causes a loss of cleavage-arresting activity 43. Similarly, an injection of an active form of MAPK 56 or constitutively-active rsk 57, into blastomeres of two-cell embryos arrests the injected blastomere in metaphase. Indeed in frog, p90rsk has been suggested to be the only MAPK substrate needed for cyclin B re-accumulation on entry to MetII, MetII spindle formation, and CSF arrest 5758. This is supported by the fact that c-Mos protein is unable to establish CSF arrest in frog egg extracts immunodepleted of p90rsk 59.

The SAC component Bub1 is phosphorlyated and activated by p90rsk 60. Bub1 34, Mad1 and Mad2 35 all appear to be required downstream of c-Mos given that the immunodepletion of these proteins blocked the establishment of CSF arrest by c-Mos in frog egg extracts. Such studies suggest a model in which CSF arrest by c-Mos is mediated by Bub1, Mad1 and Mad2 proteins.

From the above it appears that a well-defined CSF pathway has been identified in frog. However, studying SAC components maybe somewhat misleading with respect to identifying CSF. Although CSF activity and the SAC are similar in being able to induce metaphase arrest through APC/C inhibition, they may use different signalling pathways. Any arrest must be reversed by Ca²⁺ to prove physiological relevance with respect to CSF. A further issue is how CSF arrest can be achieved at MetII but not at MI metaphase (MetI) since many components of the c-Mos pathway are present and active at MetI. For example, c-Mos, MAPK, p90rsk and Bub1 are essential for suppression of S-phase between meiotic divisions 43586162 yet do not block eggs at MetI. A possible explanation is the involvement of cyclin E/cdk2, both of which are synthesized during MII 63 and inhibit the APC/C.

In frog eggs cyclin E/Cdk2 activity has been reported to play an essential role in CSF arrest. Cyclin E/Cdk2, like c-Mos, can establish metaphase arrest in egg extracts 3463. Cdk2 antisense prevents CSF arrest 64 and recombinant cyclin E/Cdk2 causes metaphase arrest in egg extracts even in the absence of c-Mos 34. The two pathways (c-Mos and cyclin E/cdk2) are therefore suggested to be independent of each other but both appear to inhibit the APC/C. CSF activity therefore may result from the coexpression of cyclin E/Cdk2 with the c-Mos/MEK/MAPK/p90rsk pathway. However, the role of cyclin E/cdk2 in CSF arrest remains to be fully elucidated since inhibiting cdk2 65, and ablation of cyclin E 66 have both been reported not disrupt CSF arrest.

Once CSF arrest has been established then many of the above proteins seem no longer required for maintenance (p90rsk, Mad2, Bub1 and cyclin E/cdk2 are all dispensable for maintenance 343559). This suggests that these proteins act upstream or independently of other effectors of CSF activity. SAC proteins may be essential to improve the efficiency of APC/C inhibition on entry into MetII arrest, yet appear redundant in the maintenance of arrest.

Whilst the c-Mos/MEK/MAPK/p90rsk/(SAC proteins) pathway is well established in the frog, its role in mammalian eggs is less clear. Although eggs from c-Mos knockout mice eventually undergo parthenogenetic activation 6768, they do MetII arrest, remaining there for 2–4 h, before going on to exit MII 69. This suggests that whilst c-Mos is critical for protracted MetII arrest, it is not required for its establishment. Loss of MEK or MAPK activity also results in parthenogenesis 21 suggesting as in frog they are downstream components of the c-Mos pathway. However, p90rsk plays no essential role in mouse because eggs from Rsk knockouts arrest at MetII 70. Furthermore SAC proteins do not mediate CSF activity since mouse eggs expressing dominant negative mutants of Bub1 and Mad2 arrest at MetII 71. Therefore the c-Mos/MEK/MAPK pathway acting independently of p90rsk is likely only to be involved in helping maintaining MetII arrest in mammals, rather than having a direct role in its establishment.

When considering all of the above, one may conclude that the c-Mos pathway is unlikely to constitute fully CSF. Recently an egg-specific protein Emi2 (or Early mitotic inhibitor 1-related protein 1; Erp1) has been identified. Emi2 degradation is Ca²⁺ dependent and likely functions to both establish and maintain CSF arrest by APC/C inhibition 7273747576. Interest in Emi2 was generated from work on a related protein Emi1, which prevents premature APC/C activation in G2 of the mitotic cell cycle by binding to the APC/C activator protein Cdc20 77. Although Emi1 itself was initially suggested to be involved in MetII arrest 78, this is now known not to be so 79, and was probably due to antibody cross-reactivity between the two Emi proteins 76.

Emi2 is a substrate of a polo-like kinase (Plk), which plays a crucial role in regulating progression through M phase 80, allowing timely activation of the APC/C at the onset of anaphase 818283. In frog eggs a role for Plx1 in Ca²⁺-mediated APC/C activation was demonstrated several years ago 81 with the authors proposing the existence of a Plx1-regulated inhibitor of the APC/C active at MetII which was inactivated by Plx1 at fertilization. A later yeast-two hybrid screen for Plx1-interacting proteins identified Emi2. Like CSF activity, Emi2 accumulates during egg maturation, is present and stable in CSF arrested egg extracts, but is rapidly degraded on Ca²⁺ addition 75. Plx1 is fully active at metaphase 84, yet at MetII it does not remove inhibition of the APC/C until at fertilization. At fertilization the target of Ca²⁺ is calmodulin-dependent protein kinase II (CamKII) 8586, which acts a priming kinase, directly phosphorylating Emi2 72. Plx1 further phosphorylates Emi2 727374, to generate a degron which is recognised by the SCF ubiquitin ligase, resulting in Emi2 polyubiquitination and destruction 74. Therefore APC/C inhibition is only removed once both CamKII and Plx1 are active.

In mammals, like frog, a Ca²⁺ signal breaks MetII arrest through a signalling pathway involving CamKII and activation the APC/C 878889. Although the full mechanism of Emi2 degradation has not yet been demonstrated in mouse, like frog, mouse Emi2 contains specific motifs for phosphorylation by both Plk and CamKII. Given that ablation of Emi2 in MetII arrested mouse eggs results in parthenogenetic activation 90, it would appear that the target of CamKII in mouse eggs is also Emi2. Supporting a role in maintaining CSF activity, Emi2 is extremely stable in MetII eggs, yet rapidly degraded by Ca²⁺ 91. As predicted for an APC/C inhibitor, it follows that on release from MetII, Emi2 destruction precedes that of cyclin B 91. These findings taken together demonstrate an essential role for Emi2 in the maintenance of MetII arrest.

On entry into MetII Emi2 is also important for APC/C inhibition, allowing cyclin B, and so MPF, accumulation. Emi2 levels are low in oocyte maturation, presumably to allow the APC/C to be active and permit passage through MI 91. Emi2 morpholinos added to maturing mouse oocytes prevent cyclin B re-accumulation on entry into MII and eggs consequentially fail to form MetII spindles, eventually decondensing their chromatin91. In this work, MetII arrest was rescued by re-addition of Emi2, expression of a D-box mutant of cyclin B or by addition of nocodazaole to induce a SAC mediated arrest. Emi2 also appears to be essential for the establishment of arrest in frog eggs 9293 suggesting a conserved mechanism in vertebrates.

A unifying hypothesis would be useful which invokes most of the CSF candidates described in both mouse and frog (the c-Mos/MEK/MAPK/p90rsk/Bub1; Mad1 and Mad2; cyclin E1/cdk2 and Emi2). Having a completely unified mechanism however looks unlikely given that the Mos/MAPK pathway in mouse does not involve p90rsk. To establish whether Emi2 and the c-Mos pathway function independently remains important but here we go on to suggest a working model of how these two pathways interact.

We propose that MetII arrest is established through Emi2-mediated APC/C inhibition, and maintained both by Emi2 and the c-Mos/MAPK pathway, which acts to stabilise MPF (Fig 2). The exact nature of the effect of the c-Mos pathway on MPF stability is still to be fully resolved however Yamamoto et al. 94 in frog eggs showed that when MPF activity reaches a critical lower level, the c-Mos/MAPK pathway suppresses cyclin B degradation in order to elevate MPF levels; whilst elevation of MPF beyond a critical upper level activates APC/C dependent cyclin B degradation 94. This suggests that Mos may help set the level of MPF activity. A CSF-arrested frog egg extract will exit MetII without cyclin B loss or a Ca²⁺ stimulus when Greatwall kinase, known to positively affect MPF activity, is immunodepleted 95. This illustrates the point that when considering the protacted nature of MetII arrest, one must consider mechanisms in the egg which are designed to respond to the sperm (Emi2 mediated APC/C inactivity) as well as those designed to keep MPF active until the time of fertilization. Our suggestion is that the c-Mos pathway may contribute to this second mechanism.

APC/C Anaphase-Promoting Complex/Cyclosome

Bub, Budding uninhibited by benzimidazole

CamKII, Calmodulin-dependent protein kinase II

CSF, Cytostatic Factor

D-box, Destruction-box

Emi2, Early mitotic inhibitor 2

Mad, mitotic-arrest deficient

MI, first meiotic division

MII, second meiotic division

MetI, metaphase I

MetII, metaphase II

MPF, Maturation (M-Phase)-Promoting Factor; CDK1/cyclin B

p90rsk, 90-kD ribosomal protein S6 kinase

The author(s) declare that they have no competing interests.

SM wrote the review. Both authors contributed to the drafting of the text.